Company / Free Cash Flow per Share
Progyny Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.25
FY2025
5-year range
$0.24 / $2.25
FY2021-FY2025
Trend
+24.7%
vs FY2024
Sector context
#64 of 142
Health Care
What the data says
At $2.25, Progyny's free cash flow per share ranks #64 of 142 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-1.78 in FY2017 to $2.25 in FY2025.
Based on SEC 10-K filings.
2.25 in FY2025 with a 5-year CAGR of +44.6%.
Improved from $1.98 to $2.25 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +38.5%
- 5-Year CAGR
- +44.6%
- 10-Year CAGR
- -
Sector benchmark
#64 of 142 in Health CareTop 45% of 142This company $2.25 Sector average $5.16
▼
-56.5% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 24.7% year-over-year.
- Ranks #64 out of 142 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.25 | +24.7% |
| FY2024 | $1.80 | -9.2% |
| FY2023 | $1.98 | +134.3% |
| FY2022 | $0.85 | +255.6% |
| FY2021 | $0.24 | -32.9% |
| FY2020 | $0.36 | +263.9% |
| FY2019 | -$0.22 | -170.9% |
| FY2018 | $0.31 | +117.2% |
| FY2017 | -$1.78 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026